Fundraising FoxRosetta Capital Ltd. — Full Portfolio
17 tracked investments · listed companies and verified rows first
Immunocore is a biotechnology company developing T cell receptor (TCR) based immunomodulating therapies for patients with cancer, infectious diseases, and autoimmune diseases.
BiotechHealthtechAbingdon, Oxfordshire
Brian Di Donato(Chief Financial Officer)David Berman(Head of Research and Development)inTina St. Leger(Chief Human Resources Officer)inBahija Jallal(Chief Executive Officer)inRobert Perez(Director)Peter Ratcliffe(Director)
Co-investorsAvego BioScience CapitalGeneral AtlanticJDRF T1D Fund
Rose Pharma is a pharmaceutical company developing therapies in gastroenterology and metabolic disorders.
BiotechHealthtechMedical Devices
Enda Kenny(CEO)inLynn Sullivan(Chief Business Officer)in
Co-investorsScientia Ventures
Sequana Medical develops the alfapump system and DSR therapy for treating fluid overload in patients with conditions such as liver disease and heart failure.
BiotechHealthtechMedical DevicesGhent, BE
Co-investorsKreos CapitalNewton BiocapitalBlackRockEQT Life SciencesVI PartnersBootstrap Europe+3 more
Aprea Therapeutics is a biopharmaceutical company developing novel cancer therapies targeting DNA damage response pathways to treat solid tumors including ovarian, colorectal, prostate, and breast cancers.
BiotechDigital HealthMedical DevicesDoylestown, US
John P. Hamill(Executive Officer)inOren Gilad(Chief Executive Officer, President)in
BoardJean-Pierre Bizzari(Director)Gabriela Gruia(Director)Rifat Pamukcu(Director)Bernd Seizinger(Director)
Co-investors5AM VenturesHealthCapRobin Hood VenturesVersant VenturesSoleus Capital
Canary Medical develops implantable orthopedic medical devices, including smart sensors and digital health solutions, for knee replacement and other surgical applications.
Digital HealthIoTMedical DevicesNew York, US
Bill Hunter(Founding Member, CEO and CMO)inFred Cushner(Founding Member and Chief Surgical Officer)Jeff Gross(Founding Member and Chief Technology Officer)
Co-investorsRelentless Pursuit PartnersHorizon Technology FinanceQuark Venture Inc.
Carrick Therapeutics is a biopharmaceutical company with a leadership team experienced in oncology drug development and commercialization.
BiotechDigital HealthHealthtechMedical DevicesBoston, US
Timothy Pearson(CEO)Ash Bahl(CSO)inJenny Horsfield(CBO)inStuart McIntosh(CMO)inDavid Sutherland(VP Finance & Controller)
Co-investorsARCH Venture PartnersB Capital GroupB4 CapitalCambridge Innovation CapitalGV (Google Ventures)Lightstone Ventures+2 more
.jpeg){kind=logo}
AMR Bio is a clinical-phase biotechnology company developing novel anti-infective drugs focused on infection prevention and combating antibiotic resistance.
BiotechHealthtechMedical Devices
Co-investorsJuno Capital PartnersSeneca Partners
BiotechCambridge
Jeffrey Buchalter(Director)Clive Morris(Executive Officer, Director)Peter Wright-Smith(Director)Douglas M. VanOrt(Director)Timothy Shannon(Executive Officer)
BoardRobert Tansley(Director)in
Co-investorsCambridge Innovation CapitalFuture Planet Capital
Instinctif is a global strategic corporate and financial communications consultancy advising C-suites and boards on investor relations, brand and reputation, ESG and sustainability, public affairs, and crisis and risk management.
Enterprise SoftwareMarketing Tech
JenaValve develops transcatheter aortic valve replacement systems to treat severe aortic regurgitation and aortic stenosis.
Digital HealthHealthtechMedical DevicesIrvine, US
Hans Figulla(Director)Markus FerrariVictoria Carr-Brendel(Executive Officer, Director)David Drachman(Executive Officer, Director)John Kilcoynein
.jpg)
BoardArnd Kaltofen(Director)in
Co-investorsAndera PartnersBain Capital Life SciencesVI PartnersAtlas VentureGimvInnovatus Capital Partners+5 more
Mission Therapeutics develops therapeutics targeting deubiquitylating enzymes (DUBs), such as USP30, which regulate ubiquitylation and processes including mitophagy and protein homeostasis.
BiotechHealthtech
Co-investorsPfizer Venture InvestmentsRoche Venture FundSofinnova PartnersSR One Capital ManagementIP Group
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AegeraEnobiaForward PharmaNovImmuneOxularParatek
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.